Saturna Capital’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Saturna Capital’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-13,000	Closed	-$353K	–	339
2015 Q4	$353K	Hold	13,000	–	–	0.01%	155
2015 Q3	$284K	Hold	13,000	–	–	0.01%	177
2015 Q2	$371K	Hold	13,000	–	–	0.01%	168
2015 Q1	$356K	Hold	13,000	–	–	0.01%	169
2014 Q4	$343K	Hold	13,000	–	–	0.01%	177
2014 Q3	$392K	Hold	13,000	–	–	0.01%	204
2014 Q2	$410K	Hold	13,000	–	–	0.01%	197
2014 Q1	$421K	Hold	13,000	–	–	0.01%	180
2013 Q4	$473K	Hold	13,000	–	–	0.01%	186
2013 Q3	$506K	Buy	13,000 +3,000	+30%	+$121K	0.01%	190
2013 Q2	$375K	Buy	+10,000	New	+$395K	0.01%	200

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Saturna Capital's MR Position: Q1 2016 in Review

Saturna Capital sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 13,000 shares — an estimated $353K sold.

Saturna Capital first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $506K in Q3 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Saturna Capital reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Saturna Capital sold 13,000 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $353K.
Saturna Capital first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
Saturna Capital's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $506K in Q3 2013.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Saturna Capital's 13F filing for Q1 2016, filed 13 May 2016.